**Question:** Thalidomide is used in -

A. Multiple Myeloma
B. Rheumatoid Arthritis
C. Behçet's Disease
D. Acute Promyelocytic Leukemia

**Core Concept:** Thalidomide is a teratogenic drug that was widely prescribed for the treatment of morning sickness during pregnancy in the 1960s and 1970s, leading to severe birth defects. It was later discovered to have anti-cancer properties.

**Why the Correct Answer is Right:** Thalidomide is primarily used in the treatment of Multiple Myeloma. Multiple myeloma is a type of blood cancer where malignant plasma cells (a type of white blood cell) accumulate in the bone marrow and cause damage to bone, kidney, and other organs. Thalidomide acts as an immunomodulator and antiangiogenic agent, which helps in controlling the disease progression and improving the patient's quality of life.

**Why Each Wrong Option is Incorrect:**

A. Rheumatoid Arthritis: Thalidomide is not an approved treatment for Rheumatoid Arthritis (RA), a systemic autoimmune disease affecting joints. Its use in RA is limited to off-label uses, and its efficacy is not comparable to approved RA treatments like biologic agents.

B. Behçet's Disease: Behçet's disease is a chronic inflammatory disorder involving the mouth, genitals, eyes, skin, and joints. Thalidomide has shown some promise in treating Behçet's disease, but it is not a primary treatment modality, and more research is needed.

C. Acute Promyelocytic Leukemia: Thalidomide is not a primary treatment for Acute Promyelocytic Leukemia (APL), a subtype of leukemia characterized by the presence of PML-RARα fusion gene. Thalidomide is primarily used as a treatment for APL in combination with arsenic trioxide, not as a standalone therapy.

**Clinical Pearl:** Thalidomide has evolved from a tragic human story to a valuable drug in hematology and oncology due to its anti-angiogenic and immunomodulatory properties. However, it has limited indications and is generally used as part of combination therapy.